The Guest Editors of this issue of Urologic Clinics of North
America have put together a comprehensive collection of articles
that provides the current knowledge on urologic cancer
immunotherapy. Expert authors have contributed clinical review
articles on the following topics: Era of personalized vaccines for
GU cancers; TCR and dendritic vaccine platforms for GU cancers;
Neo-adjuvant platforms for GU cancer immunotherapy; Immune-editing
in Cancer: Role of tumor microenvironment and immune-suppressive
pathways in localized and aggressive disease; Clinical integration
of neo-adjuvant platforms for prostate cancer immunotherapy;
Immunotherapy for muscle and non-muscle invasive bladder cancer:
BCG and beyond; Immunotherapy for metastatic bladder cancer;
Immunotherapy options for metastatic castrate-resistant prostate
cancer; Role of tissue infiltrating lymphocytes: Understanding TCR;
Therapeutic platforms for IPSC-derived CAR-T; Immune-suppression in
prostate cancer: Underlying causes and influence on response to
immunotherapy; and Racial disparity in response to immunotherapy.
Urologists will come away with the most current information they
need to improve outcomes in the urologic cancer patient.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!